Philogen S.p.A.

04/23/2025 | Press release | Distributed by Public on 04/23/2025 00:53

Philogen to attend AACR 2025 on April 25-30, 2025

Philogen to attend AACR 2025 on April 25-30, 2025

Apr 23, 2025

Claudia Comacchio is presenting a poster about Philochem's ACP3 antibody therapeutics on April 29, entitled "Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)" [Abstract Number 4781].

Gudrun Thorhallsdottir is presenting a poster about Philochem's bispecific antibodies on April 29, entitled "L19-mTNF as a novel synergistic combination partner to enhance the efficacy of CD3-based bispecific antibodies in colorectal cancer" [Abstract Number 6017].

Follow the link for more information

Philogen S.p.A. published this content on April 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 23, 2025 at 06:53 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]